David Sallman, MD | Aplastic Anemia & MDS International Foundation Return to top.

David Sallman, MD

Position / Title: 
Institution: 
H. Lee Moffitt Cancer Center & Research Institute
Primary Disease Area of Focus: 
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
  • paroxysmal nocturnal hemoglobinuria (PNH)

Dr. David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr. Sallman’s clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr. Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center. His research interests focus on the development of novel, targeted therapeutic strategies (Phase I and II clinical trials) for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), based on the underlying mutational drivers of each disease.

Practice Location: 
H. Lee Moffitt Cancer Center & Research Institute
Tampa , FL
US
Physician Status: 
  • accepting new patients
Share with addtoany.com.